Alpha Thalassemia Market is driven by gene therapy advancements

adicionou um novo artigo Health

2025-06-06 11:50:13 -

Alpha thalassemia is a hereditary blood disorder characterized by reduced synthesis of alpha-globin chains, leading to chronic anemia and complications such as splenomegaly and growth retardation. The Alpha Thalassemia Market encompasses a range of products from molecular diagnostics and high-throughput genetic assays to novel therapeutics like gene therapy, transfusion protocols, and iron...

0 Comentários 0 Compartilhamentos 547 Visualizações 0 Anterior